(Q33854247)

29 July 2017

title

Role of the mutations Trp8 => Arg and Ile15 => Thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

29 July 2017

main subject

1 reference

1 reference

Elter K

1

1 reference

29 July 2017

Erel CT

2

1 reference

29 July 2017

Cine N

3

1 reference

29 July 2017

Ozbek U

4

1 reference

29 July 2017

Hacihanefioglu B

5

1 reference

29 July 2017

Ertungealp E

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

29 July 2017

published in

Fertility and Sterility

1 reference

29 July 2017

volume

71

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

425-430

1 reference

Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

The role of luteinizing hormone-beta gene polymorphism in the onset and progression of puberty in healthy boys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Screening of the mutations in luteinizing hormone beta-subunit in patients with menstrual disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Prevalence of an immunological LH β‐subunit variant in a UK population of healthy women and women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Clinical assessment of body hair growth in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Isolation of high-molecular-weight DNA from mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900491-9

10.1016/S0015-0282(98)00491-9

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference